Artiva Biotherapeutics, Inc.
ARTV
$5.32
-$0.20-3.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 108.01M | 122.97M | 142.37M | 165.96M | 185.43M |
| Total Receivables | 767.00K | 879.00K | 1.03M | 234.00K | 1.05M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.89M | 5.68M | 5.67M | 3.81M | 2.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 112.67M | 129.52M | 149.07M | 170.00M | 188.63M |
|
|
|||||
| Total Current Assets | 112.67M | 129.52M | 149.07M | 170.00M | 188.63M |
| Net Property, Plant & Equipment | 17.36M | 18.46M | 19.83M | 20.79M | 20.43M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 919.00K | 879.00K | 499.00K | 474.00K | 525.00K |
| Total Assets | 130.94M | 148.86M | 169.39M | 191.26M | 209.58M |
|
|
|||||
| Total Accounts Payable | 355.00K | 848.00K | 1.22M | 2.04M | 1.12M |
| Total Accrued Expenses | 9.60M | 7.03M | 5.84M | 6.38M | 7.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.06M | 3.17M | 3.64M | 3.72M | 3.74M |
| Total Finance Division Other Current Liabilities | 73.00K | 73.00K | 73.00K | 73.00K | -- |
| Total Other Current Liabilities | 73.00K | 73.00K | 73.00K | 73.00K | -- |
| Total Current Liabilities | 13.09M | 11.12M | 10.77M | 12.20M | 12.25M |
|
|
|||||
| Total Current Liabilities | 13.09M | 11.12M | 10.77M | 12.20M | 12.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.88M | 8.52M | 9.58M | 10.28M | 10.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 73.00K |
| Total Liabilities | 20.97M | 19.64M | 20.35M | 22.48M | 22.94M |
|
|
|||||
| Common Stock & APIC | 440.42M | 438.91M | 437.29M | 435.78M | 433.45M |
| Retained Earnings | -330.55M | -309.78M | -288.25M | -267.00M | -246.68M |
| Treasury Stock & Other | 103.00K | 87.00K | 2.00K | -- | -129.00K |
| Total Common Equity | 109.97M | 129.22M | 149.04M | 168.78M | 186.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 109.97M | 129.22M | 149.04M | 168.78M | 186.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 109.97M | 129.22M | 149.04M | 168.78M | 186.64M |
|
|
|||||